• $1.5M
    Market Cap
  • -63.20%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
-5,000
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
+100.00%
-5,000
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
0
N/A
0
N/A
N/A
N/A
2,267
-75.79%
Total Operating Expenses
48,955
-22.70%
63,331
-47.45%
120,526
-33.84%
182,167
-78.30%
Operating Profit
-48,955
-22.70%
-63,331
-47.45%
-120,526
-33.84%
-182,167
-78.30%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-5,000
+400.00%
-1,000
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-5,000
+400.00%
-1,000
N/A
Total Nonoperating Income and Expense
-7,227
+44.14%
-5,014
+0.28%
-5,000
-600.00%
1,000
-89.34%
Income before Taxes
-56,182
-17.80%
-68,345
-45.55%
-125,526
-3.57%
-130,167
-84.32%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
50,000
N/A
Net Income
N/A
N/A
-68,345
-45.55%
-125,526
-3.57%
-130,167
-84.32%
Net Income from Continuing Operations Applicable to Common
-56,182
-17.80%
-68,345
-45.55%
-125,526
-3.57%
-130,167
-84.32%
Basic EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
0.00
+100.00%
Diluted EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
0.00
+100.00%
Basic Weighted Average Shares
83.5M
0.00%
83.5M
+2.30%
81.7M
+2.15%
80.0M
+8.96%
Diluted Weighted Average Shares
83.5M
0.00%
83.5M
+2.30%
81.7M
+2.15%
80.0M
+8.96%
Balance Sheet
Cash and Cash Equivalents
661
-72.14%
2,373
-65.13%
6,806
-90.70%
73,195
+526.94%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
661
-72.14%
2,373
-65.13%
6,806
-90.70%
73,195
+526.94%
Total Current Assets
7,911
-15.60%
9,373
-30.34%
13,456
-83.08%
79,545
+581.33%
Accumulated Depreciation
83,893
0.00%
83,893
-7.17%
90,368
0.00%
90,368
+2.57%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
7,911
-15.60%
9,373
-30.34%
13,456
-83.08%
79,545
+258.91%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
100,000
0.00%
100,000
0.00%
100,000
0.00%
100,000
N/A
Total Current Liabilities
279,189
+24.38%
224,469
+40.11%
160,207
+12.37%
142,570
-7.73%
Total Long-Term Debt
100,000
0.00%
100,000
0.00%
100,000
0.00%
100,000
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
279,189
+24.38%
224,469
+40.11%
160,207
+12.37%
142,570
-7.73%
Retained Earnings
-9.9M
+0.57%
-9.9M
+0.70%
-9.8M
+1.29%
-9.7M
+1.36%
Total Stockholders Equity
N/A
N/A
-215,096
+46.57%
-146,751
+132.85%
-63,025
-52.38%
Total Shares Outstanding
83.5M
0.00%
83.5M
0.00%
83.5M
+2.70%
81.3M
+2.52%
Cash Flow
Cash from Operating Activities
-47,979
+982.31%
-4,433
-93.32%
-66,389
+72.53%
-38,480
-81.40%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
46,267
N/A
N/A
N/A
N/A
N/A
100,000
+233.33%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
2,410.52%
N/A
N/A
N/A
Return on Assets
N/A
N/A
-598.76%
+121.81%
-269.95%
+5.46%
-255.96%
-10.68%
Return on Equity
N/A
N/A
37.78%
-68.44%
119.68%
-10.18%
133.24%
+126.92%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.03
-32.30%
0.04
-50.24%
0.08
-84.94%
0.56
+637.96%
Cash Ratio
0.002
-77.36%
0.01
-75.06%
0.04
-91.72%
0.51
+579.10%
Debt-to-Equity Ratio
N/A
N/A
-0.93
-31.78%
-1.36
-57.05%
-3.17
N/A
Debt-to-Assets Ratio
25.28
+18.48%
21.34
+43.56%
14.86
+491.15%
2.51
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow